FDA-EMA Pilot Could Further Push Global Generic Harmonization, But Will Sponsors Use It?
Industry Offers Varied Responses On US-EU Pilot Program For Complex Generics And Hybrids
The FDA-EMA parallel scientific advice pilot for complex generics is an expansion of the existing program for new drugs and biologics • Source: Alamy 
